Industry News

Dance Biopharm Announces Joint Venture with Harmony Asset for the Development of Inhaled Insulin in Multiple Countries in Asia --Joint Venture Enables Dance Biopharm to Expedite Regulatory and Commercialization Efforts in China--
AstraZeneca to pay $440m for UK biotech business
Bristol-Myers Squibb Launches Initiative to Support Search for Cure in Chronic Viral Diseases
Union threatens strike over Teva layoffs
Teva Pharma plans to cut about 5,000 employees
World's first malaria vaccine on course for 2015
Alkermes depression drug gets fast track status
OTREXUP™ (methotrexate) Injection Approved By FDA a New Treatment for Adults with Rheumatoid Arthritis, Children with Polyarticular Idiopathic Arthritis, and Adults with Psoriasis
OTREXUP™ (methotrexate) Injection Approved By FDA a New Treatment for Adults with Rheumatoid Arthritis, Children with Polyarticular Idiopathic Arthritis, and Adults with Psoriasis
St. Jude Medical Announces Acquisition and CE Mark Approval of World's First Leadless Pacemaker
MannKind Resubmits New Drug Application to U.S. FDA for AFREZZA for the Treatment of Adults with Diabetes
Pharmatek Expands Packaging Services
Genentech Announces Plans to Expand California Biologics Manufacturing Facilities
Cancer Vaccine Company DCPrime and Janssen To Collaborate on Potential New Therapy DCPrime
Marken Announces Moscow Depot Marken
Roche to invest 800 million Swiss francs in global biologic medicine manufacturing network; Investment to help meet rising demand for licensed biologics and expected pipeline growth
PharmaSmart® and Rexall Announce Breakthrough in Medication Therapy Management
Acura Pharmaceuticals Announces Settlement of Oxecta® Patent Litigation With Par Pharmaceutical and Impax Laboratories
H. D. Smith Completes Full Ownership Acquisition Of Triplefin, Solidifying End-To-End Value Chain For Pharmaceutical And Patient Support Services H. D. Smith
Ideal Implant Inc., to Sell Revolutionary Breast Implant Design to Valeant Pharmaceuticals Pending FDA Approval
FDA Clears New Continuous Blood Pressure Technology From Sotera Wireless First FDA Clearance of Passive, Non-Invasive Technique Could Transform Cardiovascular Medicine
Marken Announces Moscow Depot Marken
BAYER -FDA Approves Bayer's New Class of Drug Adempas (riociguat) tablets to Treat Adults with PAH and Persistent, Recurrent or Inoperable CTEPH
H. D. Smith Completes Full Ownership Acquisition Of Triplefin, Solidifying End-To-End Value Chain For Pharmaceutical And Patient Support Services H. D. Smith
VIVUS, Inc. Announces License Agreement for the Marketing Rights to STENDRA in the United States and Canada